19 May 2011

Botox and dermal fillers have once again topped the list of most popular non-surgical treatments, according to recent figures. Statistics from the American Society of Plastic Surgeons (ASPS) show that last year alone Botox earned $5.4 million, soft tissue fillers $1.8 million, chemical peels $1.1 million, laser hair removal $938,000, and microdermabrasion $825,000. President of the ASPS, Dr Phil Haeck, said: Injectables have remained robust despite the economy. Botox and Dysport injections are up 12 percent. Jeff Russell, executive director of the International Association for Physicians in Aesthetic Medicine (IAPAM) has noticed the vigorous growth in this area too. We are hearing from our members that minimally invasive procedures like Botox and other cosmetic injectables, medically supervised hCG weight loss, as well as laser training, microdermabrasion and chemical peels are in tremendous demand by patients, he said. Experts believe that the growth of such treatments will continue to be vigorous and have predicted high profits from Botox and other injectable treatments.